Cargando…

Hypertriglyceridemia during hospitalization independently associates with mortality in patients with COVID-19

BACKGROUND: Alteration in blood triglyceride levels have been found in patients with coronavirus disease 2019 (COVID-19). However, the association between hypertriglyceridemia and mortality in COVID-19 patients is unknown. OBJECTIVE: To investigate the association between alteration in triglyceride...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Wen, Lund, Hayley, Chen, Yiliang, Zhang, Jue, Osinski, Kristen, Jones, Stephanie Zellner, Kreuziger, Lisa Baumann, López, José A., Benjamin, Ivor J., Silverstein, Roy L., Zheng, Ze
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Lipid Association. Published by Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353976/
https://www.ncbi.nlm.nih.gov/pubmed/34470719
http://dx.doi.org/10.1016/j.jacl.2021.08.002
_version_ 1783736510071177216
author Dai, Wen
Lund, Hayley
Chen, Yiliang
Zhang, Jue
Osinski, Kristen
Jones, Stephanie Zellner
Kreuziger, Lisa Baumann
López, José A.
Benjamin, Ivor J.
Silverstein, Roy L.
Zheng, Ze
author_facet Dai, Wen
Lund, Hayley
Chen, Yiliang
Zhang, Jue
Osinski, Kristen
Jones, Stephanie Zellner
Kreuziger, Lisa Baumann
López, José A.
Benjamin, Ivor J.
Silverstein, Roy L.
Zheng, Ze
author_sort Dai, Wen
collection PubMed
description BACKGROUND: Alteration in blood triglyceride levels have been found in patients with coronavirus disease 2019 (COVID-19). However, the association between hypertriglyceridemia and mortality in COVID-19 patients is unknown. OBJECTIVE: To investigate the association between alteration in triglyceride level and mortality in hospitalized COVID-19 patients. METHODS: We conducted a retrospective study of 600 hospitalized patients with COVID-19 diagnosis (ICD10CM:U07.1) and/or SARS-CoV-2 positive testing results between March 1, 2020 and December 21, 2020 at a tertiary academic medical center in Milwaukee, Wisconsin. De-identified data, including demographics, medical history, and blood triglyceride levels were collected and analyzed. Of the 600 patients, 109 patients died. The triglyceride value on admission was considered the baseline and the peak was defined as the highest level reported during the entire period of hospitalization. Hypertriglyceridemia was defined as greater than 150 mg/dl. Logistic regression analyses were performed to evaluate the association between hypertriglyceridemia and mortality. RESULTS: There was no significant difference in baseline triglyceride levels between non-survivors (n = 109) and survivors (n = 491) [Median 127 vs. 113 mg/dl, p = 0.213]. However, the non-survivors had significantly higher peak triglyceride levels during hospitalization [Median 179 vs. 134 mg/dl, p < 0.001]. Importantly, hypertriglyceridemia independently associated with mortality [odds ratio=2.3 (95% CI: 1.4–3.7, p = 0.001)], after adjusting for age, gender, obesity, history of hypertension and diabetes, high CRP, high leukocyte count and glucocorticoid treatment in a multivariable logistic regression model. CONCLUSIONS: Hypertriglyceridemia during hospitalization is independently associated with 2.3 times higher mortality in COVID-19 patients. Prospective studies are needed to independently validate this retrospective analysis.
format Online
Article
Text
id pubmed-8353976
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher National Lipid Association. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-83539762021-08-10 Hypertriglyceridemia during hospitalization independently associates with mortality in patients with COVID-19 Dai, Wen Lund, Hayley Chen, Yiliang Zhang, Jue Osinski, Kristen Jones, Stephanie Zellner Kreuziger, Lisa Baumann López, José A. Benjamin, Ivor J. Silverstein, Roy L. Zheng, Ze J Clin Lipidol Article BACKGROUND: Alteration in blood triglyceride levels have been found in patients with coronavirus disease 2019 (COVID-19). However, the association between hypertriglyceridemia and mortality in COVID-19 patients is unknown. OBJECTIVE: To investigate the association between alteration in triglyceride level and mortality in hospitalized COVID-19 patients. METHODS: We conducted a retrospective study of 600 hospitalized patients with COVID-19 diagnosis (ICD10CM:U07.1) and/or SARS-CoV-2 positive testing results between March 1, 2020 and December 21, 2020 at a tertiary academic medical center in Milwaukee, Wisconsin. De-identified data, including demographics, medical history, and blood triglyceride levels were collected and analyzed. Of the 600 patients, 109 patients died. The triglyceride value on admission was considered the baseline and the peak was defined as the highest level reported during the entire period of hospitalization. Hypertriglyceridemia was defined as greater than 150 mg/dl. Logistic regression analyses were performed to evaluate the association between hypertriglyceridemia and mortality. RESULTS: There was no significant difference in baseline triglyceride levels between non-survivors (n = 109) and survivors (n = 491) [Median 127 vs. 113 mg/dl, p = 0.213]. However, the non-survivors had significantly higher peak triglyceride levels during hospitalization [Median 179 vs. 134 mg/dl, p < 0.001]. Importantly, hypertriglyceridemia independently associated with mortality [odds ratio=2.3 (95% CI: 1.4–3.7, p = 0.001)], after adjusting for age, gender, obesity, history of hypertension and diabetes, high CRP, high leukocyte count and glucocorticoid treatment in a multivariable logistic regression model. CONCLUSIONS: Hypertriglyceridemia during hospitalization is independently associated with 2.3 times higher mortality in COVID-19 patients. Prospective studies are needed to independently validate this retrospective analysis. National Lipid Association. Published by Elsevier Inc. 2021 2021-08-10 /pmc/articles/PMC8353976/ /pubmed/34470719 http://dx.doi.org/10.1016/j.jacl.2021.08.002 Text en © 2021 National Lipid Association. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Dai, Wen
Lund, Hayley
Chen, Yiliang
Zhang, Jue
Osinski, Kristen
Jones, Stephanie Zellner
Kreuziger, Lisa Baumann
López, José A.
Benjamin, Ivor J.
Silverstein, Roy L.
Zheng, Ze
Hypertriglyceridemia during hospitalization independently associates with mortality in patients with COVID-19
title Hypertriglyceridemia during hospitalization independently associates with mortality in patients with COVID-19
title_full Hypertriglyceridemia during hospitalization independently associates with mortality in patients with COVID-19
title_fullStr Hypertriglyceridemia during hospitalization independently associates with mortality in patients with COVID-19
title_full_unstemmed Hypertriglyceridemia during hospitalization independently associates with mortality in patients with COVID-19
title_short Hypertriglyceridemia during hospitalization independently associates with mortality in patients with COVID-19
title_sort hypertriglyceridemia during hospitalization independently associates with mortality in patients with covid-19
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353976/
https://www.ncbi.nlm.nih.gov/pubmed/34470719
http://dx.doi.org/10.1016/j.jacl.2021.08.002
work_keys_str_mv AT daiwen hypertriglyceridemiaduringhospitalizationindependentlyassociateswithmortalityinpatientswithcovid19
AT lundhayley hypertriglyceridemiaduringhospitalizationindependentlyassociateswithmortalityinpatientswithcovid19
AT chenyiliang hypertriglyceridemiaduringhospitalizationindependentlyassociateswithmortalityinpatientswithcovid19
AT zhangjue hypertriglyceridemiaduringhospitalizationindependentlyassociateswithmortalityinpatientswithcovid19
AT osinskikristen hypertriglyceridemiaduringhospitalizationindependentlyassociateswithmortalityinpatientswithcovid19
AT jonesstephaniezellner hypertriglyceridemiaduringhospitalizationindependentlyassociateswithmortalityinpatientswithcovid19
AT kreuzigerlisabaumann hypertriglyceridemiaduringhospitalizationindependentlyassociateswithmortalityinpatientswithcovid19
AT lopezjosea hypertriglyceridemiaduringhospitalizationindependentlyassociateswithmortalityinpatientswithcovid19
AT benjaminivorj hypertriglyceridemiaduringhospitalizationindependentlyassociateswithmortalityinpatientswithcovid19
AT silversteinroyl hypertriglyceridemiaduringhospitalizationindependentlyassociateswithmortalityinpatientswithcovid19
AT zhengze hypertriglyceridemiaduringhospitalizationindependentlyassociateswithmortalityinpatientswithcovid19